Skip to content
Unrated Drug recall · FDA · Published March 27, 2026

Appco Pharma recalls 1mg Prazosin capsules due to nitrosamine impurities

Appco Pharma recalls 100-count 1mg Prazosin capsules (NDC 70377-066-11) manufactured for Biocon Pharma due to detected nitrosamine impurities above safety limits. Consumers should not use these products.

🇺🇸 FDA recall #D-0419-2026DrugAppco Pharma ›
Take action

Contact the company

Recalling firmAppco Pharma LLC262 Old New Brunswick Rd Ste N · Piscataway, NJ 08854-3888
✎ GovInfoNow plain-language explainer

Appco Pharma is recalling 100-count 1mg Prazosin Hydrochloride capsules (Rx Only) because they contain unsafe levels of nitrosamine impurities. This could pose a health risk if taken as directed. Read more at govinfonow.com/recall/31383-appco-pharma-recalls-1mg-prazosin-capsules-due-to-nitrosamine-impurities.

Source Summary by GovInfoNow · govinfonow.com/recall/31383-appco-pharma-recalls-1mg-prazosin-capsules-due-to-nitrosamine-impurities · Updated August 17, 2026 · FDA enforcement record: FDA #D-0419-2026

Cite this page

“Appco Pharma recalls 1mg Prazosin capsules due to nitrosamine impurities.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/31383-appco-pharma-recalls-1mg-prazosin-capsules-due-to-nitrosamine-impurities. Based on FDA recall #D-0419-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0419-2026%22&limit=1).

The FDA announced on March 27, 2026, that Appco Pharma LLC is recalling Prazosin Hydrochloride Capsels due to the detection of N-nitroso-prazosin impurity C above acceptable limits. The agency said consumers should contact the company for a refund.

How to tell if you have it

  • Brand: Appco Pharma
  • Product: Prazosin Hydrochloride Capsules, USP, 1mg, 100-count bottle
  • NDC: 70377-066-11
  • Lots: 2404160C (Exp. 2026/MAR), 2406253C (Exp. 2026/MAY), 2407311C (Exp. 2026/JUL), 2407312C (Exp. 2026/JUL), 2408350C (Exp. 2026/JUL), 2505172C (Exp. 2027/MAY), 2506191C (Exp. 2027/JUN)
  • Quantity: 88,008 bottles

The hazard

The recall is due to cGMP deviations involving the detection of N-nitroso-prazosin impurity C above acceptable limits. The FDA's FAERS database contains 1,308 adverse-event reports naming this product, with 824 marked serious and 90 listing a death.

Context

GovInfoNow's records show Appco Pharma LLC has two other recalls on record since January 7, 2020, including a January 16, 2025, recall for Venlafaxine tablets and a January 7, 2020, recall for Ranitidine capsules. Other recent recalls of similar products include an October 16, 2025, Amerisource Health Prazosin Capsules Recall for N-nitroso impurity risk and a May 14, 2026, Asclemed Duloxetine Capsules Recall for nitrosamine impurity risk.

How to tell if you have this one

Check for the 100-count 1mg Prazosin Hydrochloride capsules with NDC 70377-066-11. Look for lot numbers 2404160C through 2506191C with expiration dates through 2027.

  • Brand
    Appco Pharma
  • Category
    Drug
FDA recall event · 3 products

All 3 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    U.S.A. Nationwide
  • NDC
    70377-066-11, 70377-067-11, 70377-068-11
Recall numberProduct, codes & lotsQuantity
D-0419-2026Prazosin Hydrochloride Capsules, USP, 1mg, 100-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ, Manufactured by: Appco Pharma LLC, Piscataway, NJ, NDC 70377-066-11.; Lot:2404160C, Exp.:2026/MAR; 2406253C, Exp.:2026/MAY; 2407311C, Exp.: 2026/JUL; 2407312C, Exp.:2026/JUL; 2408350C, Exp.:2026/JUL; 2505172C, Exp.:2027/MAY; 2506191C, Exp.: 2027/JUN.88,008 bottles- 100's count
D-0420-2026Prazosin Hydrochloride Capsules, USP, 2mg, 100-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ, Manufactured by: Appco Pharma LLC, Piscataway, NJ, NDC 70377-067-11.; Lot:2404153UC, Exp.: 2026/MAR; 2404154UC, Exp.:2026/MAR; 2502055UC, Exp.: 2027/JAN; 2505173UC, Exp.: 2027/MAY; 2505175UC, Exp.: 2027/MAY.58,896 bottles- 100's count
D-0421-2026Prazosin Hydrochloride Capsules, USP, 5mg, 100-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ, Manufactured by: Appco Pharma LLC, Piscataway, NJ, NDC 70377-068-11.; Lot:2406255UC, Exp.: 2026/MAY; 2406256UC, Exp.: 2026/JUL; 2407313UC Exp.: 2026/JUL; 2408351UC, Exp.: 2026/JUL; 2408352UC , Exp.: 2026/JUL; 2509311UC, Exp.: 2027/SEP. .28,157 bottles- 100's count
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Identify the product by checking the NDC code 70377-066-11 and lot numbers listed in the recall notice.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “U.S.A. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 12 days after the firm started it.

1. Firm started the recall: Mar 27, 202612. FDA classified it Class II: Mar 31, 202623. Published in FDA’s Enforcement Report: Apr 8, 202632026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0419-2026 (March 27, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0419-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA